Compugen Ltd (CGEN)
1.935
-0.02
(-0.77%)
USD |
NASDAQ |
Apr 16, 13:28
Compugen Enterprise Value: 123.90M for April 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 123.90M |
| April 12, 2024 | 140.01M |
| April 11, 2024 | 151.65M |
| April 10, 2024 | 151.65M |
| April 09, 2024 | 160.61M |
| April 08, 2024 | 157.92M |
| April 05, 2024 | 165.98M |
| April 04, 2024 | 157.03M |
| April 03, 2024 | 166.87M |
| April 02, 2024 | 158.82M |
| April 01, 2024 | 170.45M |
| March 28, 2024 | 180.30M |
| March 27, 2024 | 176.72M |
| March 26, 2024 | 173.14M |
| March 25, 2024 | 175.83M |
| March 22, 2024 | 185.67M |
| March 21, 2024 | 188.36M |
| March 20, 2024 | 190.15M |
| March 19, 2024 | 180.30M |
| March 18, 2024 | 188.36M |
| March 15, 2024 | 193.73M |
| March 14, 2024 | 189.26M |
| March 13, 2024 | 200.89M |
| March 12, 2024 | 200.00M |
| March 11, 2024 | 198.21M |
| Date | Value |
|---|---|
| March 08, 2024 | 212.53M |
| March 07, 2024 | 186.57M |
| March 06, 2024 | 178.51M |
| March 05, 2024 | 177.62M |
| March 04, 2024 | 213.43M |
| March 01, 2024 | 185.67M |
| February 29, 2024 | 180.30M |
| February 28, 2024 | 179.41M |
| February 27, 2024 | 186.57M |
| February 26, 2024 | 178.51M |
| February 23, 2024 | 158.82M |
| February 22, 2024 | 157.03M |
| February 21, 2024 | 163.29M |
| February 20, 2024 | 164.19M |
| February 16, 2024 | 163.48M |
| February 15, 2024 | 156.35M |
| February 14, 2024 | 154.56M |
| February 13, 2024 | 143.85M |
| February 12, 2024 | 157.24M |
| February 09, 2024 | 140.28M |
| February 08, 2024 | 140.28M |
| February 07, 2024 | 136.71M |
| February 06, 2024 | 150.10M |
| February 05, 2024 | 149.21M |
| February 02, 2024 | 151.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.55M
Minimum
Sep 29 2022
1.472B
Maximum
Aug 25 2020
347.10M
Average
192.64M
Median
Enterprise Value Benchmarks
| Pluri Inc | 25.64M |
| BioLine Rx Ltd | 17.95M |
| XTL Biopharmaceuticals Ltd | 12.40M |
| Can Fite Biofarma Ltd | 1.408M |
| BiomX Inc | 12.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.713M |
| Revenue (Quarterly) | 33.46M |
| Total Expenses (Quarterly) | 15.48M |
| EPS Diluted (Quarterly) | 0.12 |
| Profit Margin (Quarterly) | 29.03% |
| Earnings Yield | -10.85% |
| Normalized Earnings Yield | -10.85 |